BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ma L, Zeng Y, Wei J, Yang D, Ding G, Liu J, Shang J, Kang Y, Ji X. Knockdown of LOXL1 inhibits TGF-β1-induced proliferation and fibrogenesis of hepatic stellate cells by inhibition of Smad2/3 phosphorylation. Biomed Pharmacother 2018;107:1728-35. [PMID: 30257391 DOI: 10.1016/j.biopha.2018.08.156] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Zeltz C, Pasko E, Cox TR, Navab R, Tsao MS. LOXL1 Is Regulated by Integrin α11 and Promotes Non-Small Cell Lung Cancer Tumorigenicity. Cancers (Basel) 2019;11:E705. [PMID: 31121900 DOI: 10.3390/cancers11050705] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
2 Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells 2019;8:E1419. [PMID: 31718044 DOI: 10.3390/cells8111419] [Cited by in Crossref: 96] [Cited by in F6Publishing: 107] [Article Influence: 32.0] [Reference Citation Analysis]
3 Yang N, Cao DF, Yin XX, Zhou HH, Mao XY. Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases. Biomed Pharmacother 2020;131:110791. [PMID: 33152948 DOI: 10.1016/j.biopha.2020.110791] [Reference Citation Analysis]
4 Wang R, Zhang D, Tang D, Sun K, Peng J, Zhu W, Yin S, Wu Y. Amygdalin inhibits TGFβ1-induced activation of hepatic stellate cells (HSCs) in vitro and CCl4-induced hepatic fibrosis in rats in vivo. Int Immunopharmacol 2021;90:107151. [PMID: 33296784 DOI: 10.1016/j.intimp.2020.107151] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhang L, Xing R, Huang Z, Ding L, Zhang L, Li M, Li X, Wang P, Mao J. Synovial Fibrosis Involvement in Osteoarthritis. Front Med (Lausanne) 2021;8:684389. [PMID: 34124114 DOI: 10.3389/fmed.2021.684389] [Reference Citation Analysis]
6 Liu Q, Lv C, Huang Q, Zhao L, Sun X, Ning D, Liu J, Jiang Y, Jin S. ECM1 modified HF-MSCs targeting HSC attenuate liver cirrhosis by inhibiting the TGF-β/Smad signaling pathway. Cell Death Discov 2022;8:51. [PMID: 35136027 DOI: 10.1038/s41420-022-00846-4] [Reference Citation Analysis]
7 Ma L, Liu J, Xiao E, Ning H, Li K, Shang J, Kang Y. MiR-15b and miR-16 suppress TGF-β1-induced proliferation and fibrogenesis by regulating LOXL1 in hepatic stellate cells. Life Sci 2021;270:119144. [PMID: 33545201 DOI: 10.1016/j.lfs.2021.119144] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Cai W, Yu D, Fan J, Liang X, Jin H, Liu C, Zhu M, Shen T, Zhang R, Hu W, Wei Q, Yu J. Quercetin inhibits transforming growth factor β1-induced epithelial-mesenchymal transition in human retinal pigment epithelial cells via the Smad pathway. Drug Des Devel Ther 2018;12:4149-61. [PMID: 30584279 DOI: 10.2147/DDDT.S185618] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
9 Chen W, Yang A, Jia J, Popov YV, Schuppan D, You H. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis. Hepatology 2020;72:729-41. [DOI: 10.1002/hep.31236] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 10.5] [Reference Citation Analysis]
10 Hu Q, Masuda T, Kuramitsu S, Tobo T, Sato K, Kidogami S, Nambara S, Ueda M, Tsuruda Y, Kuroda Y, Ito S, Oki E, Mori M, Mimori K. Potential association of LOXL1 with peritoneal dissemination in gastric cancer possibly via promotion of EMT. PLoS One 2020;15:e0241140. [PMID: 33095806 DOI: 10.1371/journal.pone.0241140] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
11 Greene AG, Eivers SB, Dervan EWJ, O'Brien CJ, Wallace DM. Lysyl Oxidase Like 1: Biological roles and regulation. Exp Eye Res 2020;193:107975. [PMID: 32070696 DOI: 10.1016/j.exer.2020.107975] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
12 Jin J, Saiding Q, Wang X, Qin M, Xiang Y, Cheng R, Cui W, Chen X. Rapid Extracellular Matrix Remodeling via Gene‐Electrospun Fibers as a “Patch” for Tissue Regeneration. Adv Funct Mater 2021;31:2009879. [DOI: 10.1002/adfm.202009879] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yang A, Yan X, Xu H, Fan X, Zhang M, Huang T, Li W, Chen W, Jia J, You H. Selective depletion of hepatic stellate cells-specific LOXL1 alleviates liver fibrosis. FASEB J 2021;35:e21918. [PMID: 34569648 DOI: 10.1096/fj.202100374R] [Reference Citation Analysis]
14 Schlötzer-Schrehardt U, Zenkel M. The role of lysyl oxidase-like 1 (LOXL1) in exfoliation syndrome and glaucoma. Exp Eye Res 2019;189:107818. [PMID: 31563608 DOI: 10.1016/j.exer.2019.107818] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
15 Wang ZJ, Yu H, Hao JJ, Peng Y, Yin TT, Qiu YN. PM2.5 promotes Drp1-mediated mitophagy to induce hepatic stellate cell activation and hepatic fibrosis via regulating miR-411. Exp Cell Res 2021;407:112828. [PMID: 34508745 DOI: 10.1016/j.yexcr.2021.112828] [Reference Citation Analysis]
16 Bai T, Liu Y, Li B. LncRNA LOXL1‐AS1/miR‐let‐7a‐5p/ EGFR ‐related pathway regulates the doxorubicin resistance of prostate cancer DU‐145 cells. IUBMB Life 2019;71:1537-51. [DOI: 10.1002/iub.2075] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 7.7] [Reference Citation Analysis]
17 Ni XX, Li XY, Wang Q, Hua J. Regulation of peroxisome proliferator-activated receptor-gamma activity affects the hepatic stellate cell activation and the progression of NASH via TGF-β1/Smad signaling pathway. J Physiol Biochem 2021;77:35-45. [PMID: 33188625 DOI: 10.1007/s13105-020-00777-7] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Yang Y, Ye WL, Zhang RN, He XS, Wang JR, Liu YX, Wang Y, Yang XM, Zhang YJ, Gan WJ. The Role of TGF-β Signaling Pathways in Cancer and Its Potential as a Therapeutic Target. Evid Based Complement Alternat Med 2021;2021:6675208. [PMID: 34335834 DOI: 10.1155/2021/6675208] [Reference Citation Analysis]